0001829126-26-002408.txt : 20260317 0001829126-26-002408.hdr.sgml : 20260317 20260317165915 ACCESSION NUMBER: 0001829126-26-002408 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260317 DATE AS OF CHANGE: 20260317 EFFECTIVENESS DATE: 20260317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KALA BIO, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-576813 FILM NUMBER: 26763099 BUSINESS ADDRESS: STREET 1: 1167 MASSACHUSETTS AVENUE CITY: ARLINGTON STATE: MA ZIP: 02476 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 1167 MASSACHUSETTS AVENUE CITY: ARLINGTON STATE: MA ZIP: 02476 FORMER COMPANY: FORMER CONFORMED NAME: Kala Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20091223 D 1 primary_doc.xml X0708 D LIVE 0001479419 KALA BIO, Inc. 1167 MASSACHUSETTS AVENUE ARLINGTON MA MASSACHUSETTS 02476 781-996-5252 DELAWARE None Kala Pharmaceuticals, Inc. Corporation true Avi Minkowitz 1167 Massachusetts Avenue Arlington MA MASSACHUSETTS 02476 Executive Officer Director Hillel Posen 1167 Massachusetts Avenue Arlington MA MASSACHUSETTS 02476 Director Chaim Berger 1167 Massachusetts Avenue Arlington MA MASSACHUSETTS 02476 Director Yonatan Colman 1167 Massachusetts Avenue Arlington MA MASSACHUSETTS 02467 Director Brendan Purdy 1167 Massachusetts Avenue Arlington MA MASSACHUSETTS 02467 Director Pharmaceuticals Decline to Disclose 06b false 2026-03-03 false true false 1753500 1753500 1753500 0 The total offering amount is based off the closing price of KALA BIO, Inc.'s common stock on March 3, 2026 ($0.3507) for 5 million shares of common stock being issued. false 1 0 0 0 false KALA BIO, Inc. /s/ Avi Minkowitz Avi Minkowitz Chief Executive Officer 2026-03-17